相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Intranasal immunization with live attenuated influenza vaccine plus chitosan as an adjuvant protects mice against homologous and heterologous virus challenge
Xueliang Wang et al.
ARCHIVES OF VIROLOGY (2012)
A Replication-Incompetent PB2-Knockout Influenza A Virus Vaccine Vector
Sylvia T. Victor et al.
JOURNAL OF VIROLOGY (2012)
Special Focus: Influenza Vaccines
Ronald Ellis et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Vaccine effectiveness in older individuals: What has been learned from the influenza-vaccine experience
Pierre-Olivier Lang et al.
AGEING RESEARCH REVIEWS (2011)
New Strategies for the Development of H5N1 Subtype Influenza Vaccines Progress and Challenges
John Steel
BIODRUGS (2011)
Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double-blind placebo-controlled trial
L. E. Davidson et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2011)
Replication-incompetent influenza A viruses that stably express a foreign gene
Makoto Ozawa et al.
JOURNAL OF GENERAL VIROLOGY (2011)
Contributions of Antinucleoprotein IgG to Heterosubtypic Immunity against Influenza Virus
Mark W. LaMere et al.
JOURNAL OF IMMUNOLOGY (2011)
Receptor Binding Profiles of Avian Influenza Virus Hemagglutinin Subtypes on Human Cells as a Predictor of Pandemic Potential
Holly Shelton et al.
JOURNAL OF VIROLOGY (2011)
Modifications in the Polymerase Genes of a Swine-Like Triple-Reassortant Influenza Virus To Generate Live Attenuated Vaccines against 2009 Pandemic H1N1 Viruses
Lindomar Pena et al.
JOURNAL OF VIROLOGY (2011)
A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older
Bruce D. Forrest et al.
VACCINE (2011)
Live attenuated influenza vaccine (LAIV) impacts innate and adaptive immune responses
Paula A. Lanthier et al.
VACCINE (2011)
Improved hatchability and efficient protection after in ovo vaccination with live-attenuated H7N2 and H9N2 avian influenza viruses
Yibin Cai et al.
VIROLOGY JOURNAL (2011)
Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant
Zhiwei Sui et al.
ARCHIVES OF VIROLOGY (2010)
Alternative Live-Attenuated Influenza Vaccines Based on Modifications in the Polymerase Genes Protect against Epidemic and Pandemic Flu
Alicia Solorzano et al.
JOURNAL OF VIROLOGY (2010)
Live attenuated influenza virus vaccines by computer-aided rational design
Steffen Mueller et al.
NATURE BIOTECHNOLOGY (2010)
Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant
Zhiwei Sui et al.
VACCINE (2010)
Live Attenuated Influenza Viruses Containing NS1 Truncations as Vaccine Candidates against H5N1 Highly Pathogenic Avian Influenza
John Steel et al.
JOURNAL OF VIROLOGY (2009)
Mixed Infection and the Genesis of Influenza Virus Diversity
Elodie Ghedin et al.
JOURNAL OF VIROLOGY (2009)
Preclinical Evaluation of a Replication-Deficient Intranasal ΔNS1 H5N1 Influenza Vaccine
Julia Romanova et al.
PLOS ONE (2009)
Efficacy and safety of a live attenuated influenza vaccine in adults 60 years of age and older
Pierre J. T. De Villiers et al.
VACCINE (2009)
Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine
Sarah A. Kopecky-Bromberg et al.
VACCINE (2009)
Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults
Ruth A. Karron et al.
VACCINE (2009)
Immunogenicity and Protective Efficacy of a Live Attenuated H5N1 Vaccine in Nonhuman Primates
Shufang Fan et al.
PLOS PATHOGENS (2009)
Prepandemic influenza vaccine H5N1 (split virion, inactivated, adjuvanted) [Prepandrix (TM)] - A review of its use as an active immunization against influenza A subtype H5N1 virus
Natalie J. Carter et al.
BIODRUGS (2008)
Attenuated influenza A viruses with modified cleavage sites in hemagglutinin as live vaccines
Juergen Stech
EXPERT REVIEW OF VACCINES (2008)
Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza
Christopher S. Ambrose et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2008)
An avian live attenuated master backbone for potential use in epidemic and pandemic influenza vaccines
Danielle Hickman et al.
JOURNAL OF GENERAL VIROLOGY (2008)
The structural basis for cap binding by influenza virus polymerase subunit PB2
Delphine Guilligay et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Characterization of influenza virus variants with different sizes of the non-structural (NS) genes and their potential as a live influenza vaccine in poultry
L. Wang et al.
VACCINE (2008)
Novel approach to the development of effective H5N1 influenza a virus vaccines: Use of M2 cytoplasmic tail mutants
Tokiko Watanabe et al.
JOURNAL OF VIROLOGY (2008)
Toxicological evaluation of live attenuated, cold-adapted H5N1 vaccines in ferrets
H. Jin et al.
VACCINE (2007)
Live attenuated versus inactivated influenza vaccine in infants and young children
Robert B. Belshe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Priming with cold-adapted influenza A does not prevent infection but elicits long-lived protection against supralethal challenge with heterosubtypic virus
Timothy J. Powell et al.
JOURNAL OF IMMUNOLOGY (2007)
A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates
Haichen Song et al.
JOURNAL OF VIROLOGY (2007)
Live attenuated influenza virus expressing human interleukin-2 reveals increased immunogenic potential in young and aged hosts
Boris Ferko et al.
JOURNAL OF VIROLOGY (2006)
Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections
Shai Ashkenazi et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets
Amorsolo L. Suguitan et al.
PLOS MEDICINE (2006)
Glycolipid α-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice
Shin-ichiro Fujii et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The cytoplasmic tail of the influenza A virus M2 protein plays a role in viral assembly
Kiyoko Iwatsuki-Horimoto et al.
JOURNAL OF VIROLOGY (2006)
Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine:: phase I randomised trial
Jean-Louis Bresson et al.
LANCET (2006)
Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine
JJ Treanor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Probable person-to-person transmission of avian influenza A (H5N1)
K Ungchusak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
alpha-galactosylceramide therapy for autoimmune diseases: Prospects and obstacles
L Van Kaer
NATURE REVIEWS IMMUNOLOGY (2005)
Molecular adjuvants for mucosal immunity
FN Toka et al.
IMMUNOLOGICAL REVIEWS (2004)
Imparting temperature sensitivity and attenuation in ferrets to A/Puerto Rico/8/34 influenza virus by transferring the genetic signature for temperature sensitivity from cold-adapted A/Ann Arbor/6/60
H Jin et al.
JOURNAL OF VIROLOGY (2004)
Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60
H Jin et al.
VIROLOGY (2003)
Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy A meta-analysis
WEP Beyer et al.
VACCINE (2002)
Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines
BR Murphy et al.
VIRAL IMMUNOLOGY (2002)
Chitosan and its derivatives in mucosal drug and vaccine delivery
IM van der Lubben et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2001)
Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses
M Hatta et al.
SCIENCE (2001)
Chitosan: some pharmaceutical and biological aspects - an update
AK Singla et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2001)
Pandemic threat posed by avian influenza A viruses
T Horimoto et al.
CLINICAL MICROBIOLOGY REVIEWS (2001)
A mucosal vaccine against diphtheria:: formulation of cross reacting material (CRM197) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery
EA McNeela et al.
VACCINE (2000)
分享论文
